Stocks' study renews concerns over insider trading on oncology drugs.
Merrill
M
Goozner
D000970:Antineoplastic Agents / Q000191:economics*; D002986:Clinical Trials as Topic / Q000191:economics; D003219:Confidentiality; D017277:Drug Approval; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007449:Investments; D010819:Physician's Role; D010820:Physicians / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration
D000970:Antineoplastic Agents